Tag: Sentinel Initiative
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA doesn't stop monitoring generic drugs after approval. Using real-time data, patient reports, and AI tools, it tracks safety issues across billions of prescriptions to ensure generics remain safe and effective.